Departamento de Clínica Médica, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.
Neuroimmunomodulation. 2012;19(3):158-70. doi: 10.1159/000331264. Epub 2012 Jan 18.
Mechanisms involved in stress-induced asthmatic alterations have been poorly characterised. We assessed whether inducible nitric oxide synthase (iNOS) inhibition modulates the stress-amplified lung parenchyma responsiveness, oxidative stress and extracellular matrix remodelling that was previously increased by chronic lung inflammation. Guinea pigs were subjected to 7 exposures to ovalbumin (1-5 mg/ml) or saline (OVA and SAL groups) over 4 weeks. To induce behavioural stress, animals were subjected to a forced swimming protocol (5 times/week, over 2 weeks; SAL-Stress and OVA-Stress groups) 24 h after the 4th inhalation. 1400W (iNOS-specific inhibitor) was administered intraperitoneally in the last 4 days of the protocol (SAL-1400W, OVA-1400W, SAL-Stress+1400W and OVA-Stress+1400W groups). Seventy-two hours after the last inhalation, animals were anaesthetised and exsanguinated, and adrenal glands were removed. Lung tissue resistance and elastance were evaluated by oscillatory mechanics and submitted for histopathological evaluation. Stressed animals had higher adrenal weights compared to non-stressed groups, which were reduced by 1400W treatment. Behavioural stress in sensitised animals amplified the resistance and elastance responses after antigen challenge, numbers of eosinophils and iNOS+ cells, actin content and 8-iso-PGF2α density in the distal lung compared to the OVA group. 1400W treatment in ovalbumin-exposed and stressed animals reduced lung mechanics, iNOS+ cell numbers and 8-iso-PGF2α density compared to sensitised and stressed animals that received vehicle treatment. We concluded that stress amplifies the distal lung constriction, eosinophilic inflammation, iNOS expression, actin content and oxidative stress previously induced by chronic lung inflammation. iNOS-derived NO contributes to stress-augmented lung tissue functional alterations in this animal model and is at least partially due to activation of the oxidative stress pathway.
应激诱导哮喘改变的机制尚未得到很好的描述。我们评估了诱导型一氧化氮合酶(iNOS)抑制是否调节了先前由慢性肺炎症引起的应激增强的肺实质反应性、氧化应激和细胞外基质重塑。豚鼠接受了 7 次卵清蛋白(1-5mg/ml)或生理盐水(OVA 和 SAL 组)暴露,共 4 周。为了诱导行为应激,动物在第 4 次吸入后 24 小时接受强制游泳方案(每周 5 次,共 2 周;SAL-Stress 和 OVA-Stress 组)。在方案的最后 4 天,腹腔内给予 1400W(iNOS 特异性抑制剂)(SAL-1400W、OVA-1400W、SAL-Stress+1400W 和 OVA-Stress+1400W 组)。最后一次吸入后 72 小时,麻醉动物并放血,取出肾上腺。通过振荡力学评估肺组织阻力和弹性,并进行组织病理学评估。与非应激组相比,应激动物的肾上腺重量更高,而 1400W 处理可降低应激动物的肾上腺重量。在致敏动物中,行为应激增强了抗原挑战后远端肺的阻力和弹性反应、嗜酸性粒细胞和 iNOS+细胞的数量、远端肺的肌动蛋白含量和 8-异前列腺素 F2α密度,与 OVA 组相比。与接受载体处理的致敏和应激动物相比,在卵清蛋白暴露和应激动物中给予 1400W 治疗可降低肺力学、iNOS+细胞数量和 8-异前列腺素 F2α密度。我们得出结论,应激增强了慢性肺炎症先前引起的远端肺收缩、嗜酸性粒细胞炎症、iNOS 表达、肌动蛋白含量和氧化应激。iNOS 衍生的 NO 有助于该动物模型中应激增强的肺组织功能改变,至少部分是由于氧化应激途径的激活。